Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Evaluation of the Clinical, Technical, and Financial Aspects of Cost-Effectiveness Analysis of Artificial Intelligence in Medicine: Scoping Review and Framework of Analysis
28
Zitationen
4
Autoren
2022
Jahr
Abstract
Current studies on the cost-effectiveness of AI do not allow to determine if the investigated AI solutions are clinically, technically, and economically viable. Further research and improved reporting on these dimensions seem relevant to recommend and assess potential use cases for this technology.
Ähnliche Arbeiten
Meta-analysis in clinical trials
1986 · 38.948 Zit.
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
2018 · 38.299 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 37.679 Zit.
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 · 33.756 Zit.
RoB 2: a revised tool for assessing risk of bias in randomised trials
2019 · 29.194 Zit.